IP Library Granted Patent US 8,715,922
Granted Patent B2
US 8,715,922 · App. 10/722,045 · Granted May 6, 2014

Virus causing respiratory tract illness in susceptible mammals

Inventors: Jan Cornelius De Jong (Gouda, NL); Ronaldus Adrianus Maria Fouchier (Rotterdam, NL); Bernadetta Gerarda Van Den Hoogen (Rotterdam, NL); Albertus Dominicus Marcellinus Erasmus Osterhaus (Bunnik, NL); Jan Groen (Laguna Niguel, CA)
Assignee: ViroNovative
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,715,922
App. No.
10/722,045
Granted
May 6, 2014
Kind
B2
Abstract

The invention relates to the field of virology. The invention provides an isolated essentially mammalian negative-sense single stranded RNA virus (MPV) within the subfamily Pneumovirinae of the family Paramyxoviridae and identifiable as phylogenetically corresponding to the genus Metapneumovirus and components thereof.

Claims (9)

1. A method for detecting a human metapneumovirus in a sample, wherein the method comprises contacting the sample with a nucleic acid encoding an amino acid sequence that is greater than 88% identical to the amino acid sequence of the N protein of MPV isolate 00-1, SEQ ID NO.: 1.

2. The method of claim 1 , wherein the amino acid sequence is: SEQ ID No.: 1.

3. A method for detecting a human metapneumovirus in a sample, wherein the method comprises contacting the sample with an antibody that specifically binds to a protein that is greater than 88% identical to the amino acid sequence of the N protein of MPV isolate 00-1, SEQ ID NO.: 1.

4. The method of claim 3 , wherein the protein consists of an amino acid sequence of SEQ ID No.: 1.

5. The method of claim 4 , wherein the method further comprises an immune fluorescence assay.

6. A method for detecting a human metapneumovirus in a sample, wherein the method comprises contacting the sample with a first nucleic acid that is at least 90% homologous to a second nucleic acid, wherein the second nucleic acid encodes, or wherein the second nucleic acid is complementary to the nucleic acid that encodes, a protein, or fragment thereof, consisting of a sequence that is greater than 88% identical to the amino acid sequence of the N protein of MPV isolate 00-1, SEQ ID NO.: 1.

7. A method for detecting a human metapneumovirus in a sample, wherein the method comprises contacting the sample with one or more nucleic acids that are at least 90% homologous to the genome or antigenome of the virus isolate deposited as I-2614 with CNCM, Paris.

8. The method of claim 1 or 7 , wherein the nucleic acid sequence is at least 90% identical to SEQ ID No.: 1.

9. A method for detecting an antibody against human metapneumovirus in a sample, wherein the method comprises contacting the sample with a protein comprising the amino acid sequence of: SEQ ID No.: 1.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2016
From: VIRONOVATIVE B.V.
To: ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM
Reel/Frame 037726/0550 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2014
From: DE JONG, JAN CORNELIUS; FOUCHIER, RONALDUS ADRIANUS MARIA; VAN DEN HOOGEN, BERNADETTA GERARDA; OSTERHAUS, ALBERTUS DOMINICUS MARCELLINUS ERASMUS; GROEN, JAN
To: VIRONOVATIVE BV
Reel/Frame 032142/0824 →
Priority Claims (2)
EP 01200213 · Jan 19, 2001 · regional
EP 01203985 · Oct 18, 2001 · regional
Continuity (2)
Continuation 10466811
Related Publication 20050053919A1 · Mar 10, 2005